copper sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4282	7758-99-8

Description:

Molecule	Description
Synonyms: cupric sulfate copper sulfate copper sulfate pentahydrate cupric sulfate pentahydrate cupric sulfate anhydrous	A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae. Molecular weight: 159.60 Formula: CuO4S CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: ALOGS: ROTB: None

Molecule

Description

Synonyms:

cupric sulfate
copper sulfate
copper sulfate pentahydrate
cupric sulfate pentahydrate
cupric sulfate anhydrous

A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.

Molecular weight: 159.60
Formula: CuO4S
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA:
ALOGS:
ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
May 5, 1987	FDA	ABRAXIS PHARM

FDA Adverse Event Reporting System (Female)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Contraindicated product administered	120.13	11.13	4	40273	217644	63231101
Treatment failure	91.08	11.13	10	40267	199033	63249712
Product dose omission issue	87.11	11.13	336	39941	233977	63214768
Systemic lupus erythematosus	85.03	11.13	15	40262	208903	63239842
Maternal exposure during pregnancy	84.92	11.13	18	40259	220044	63228701
Drug intolerance	83.46	11.13	46	40231	308615	63140130
Product use issue	83.15	11.13	19	40258	220501	63228244
Product use in unapproved indication	81.92	11.13	9	40268	179071	63269674
Diarrhoea	81.19	11.13	749	39528	714617	62734128
Glossodynia	76.94	11.13	11	40266	178865	63269880

Showing 1 to 10 of 125 entries

Previous1 2 3 4 5…13Next

FDA Adverse Event Reporting System (Male)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Off label use	81.10	12.18	98	23394	419426	34514013
Product use in unapproved indication	63.15	12.18	4	23488	117495	34815944
Fatigue	59.64	12.18	439	23053	370214	34563225
Plasma cell myeloma	51.01	12.18	97	23395	41940	34891499
Product dose omission issue	50.58	12.18	186	23306	119525	34813914
Completed suicide	48.15	12.18	5	23487	98163	34835276
Respiratory tract infection bacterial	43.24	12.18	22	23470	1760	34931679
Diarrhoea	40.24	12.18	419	23073	389493	34543946
Respiratory tract infection viral	38.73	12.18	23	23469	2494	34930945
Full blood count decreased	38.72	12.18	54	23438	18034	34915405

Showing 1 to 10 of 49 entries

Previous1 2 3 4 5Next

FDA Adverse Event Reporting System (Geriatric)

Show entries

Search:

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Completed suicide	130.48	10.95	6	50546	245761	79448075
Product use in unapproved indication	121.28	10.95	10	50542	250349	79443487
Off label use	120.43	10.95	247	50305	906968	78786868
Product dose omission issue	99.62	10.95	364	50188	247173	79446663
Toxicity to various agents	97.30	10.95	75	50477	421465	79272371
Contraindicated product administered	83.09	10.95	4	50548	157534	79536302
Treatment failure	79.35	10.95	8	50544	170478	79523358
Device expulsion	72.98	10.95	86	50466	25775	79668061
Fall	68.10	10.95	535	50017	487094	79206742
Drug intolerance	67.51	10.95	42	50510	264077	79429759

Showing 1 to 10 of 153 entries

Previous1 2 3 4 5…16Next

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Show entries

Search:

Source	Code	Description
ATC	V03AB20	VARIOUS ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS Antidotes
CHEBI has role	CHEBI:33287	fertilizers
CHEBI has role	CHEBI:139492	sensitizers
CHEBI has role	CHEBI:149552	emetics
MeSH PA	D000931	Antidotes
MeSH PA	D002491	Central Nervous System Agents
MeSH PA	D004639	Emetics
MeSH PA	D005765	Gastrointestinal Agents
MeSH PA	D018373	Peripheral Nervous System Agents
MeSH PA	D020011	Protective Agents

Showing 1 to 10 of 10 entries

Previous1Next

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Hypocupremia	contraindication	19577007
Wilson's disease	contraindication	88518009

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Show entries

Search:

Formulation strength	Trade name	Applicant	Application number	Approval date	Type	Dose form	Route	Exclusivity date	Description
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (1ML)	TRALEMENT	AM REGENT	N209376	July 2, 2020	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (5ML)	TRALEMENT	AM REGENT	N209376	Dec. 2, 2020	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY
EQ 60MCG COPPER/ML;EQ 3MCG BASE/ML;EQ 6MCG SELENIUM/ML;EQ 1000MCG BASE/ML (1ML)	MULTRYS	AM REGENT	N209376	June 30, 2021	RX	SOLUTION	INTRAVENOUS	April 30, 2024	NEW CHEMICAL ENTITY

Showing 1 to 3 of 3 entries

Previous1Next

Bioactivity Summary:

None

External reference:

Show entries

Search:

ID	Source
000855	NDDF
001946	NDDF
007446	NDDF
1999541	RXNORM
24462	PUBCHEM_CID
3686	MMSL
37539	MMSL
39943	MMSL
4017628	VANDF
4017650	VANDF

Showing 1 to 10 of 29 entries

Previous1 2 3Next

Pharmaceutical products:

Show entries

Search:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
C-Nate DHA	HUMAN PRESCRIPTION DRUG LABEL	13	23359-105	CAPSULE, GELATIN COATED	1 mg	ORAL	unapproved drug other	15 sections
Centratex	HUMAN PRESCRIPTION DRUG LABEL	13	23359-100	CAPSULE	0.80 mg	ORAL	unapproved drug other	13 sections
Concept DHA	HUMAN PRESCRIPTION DRUG LABEL	15	52747-621	CAPSULE, LIQUID FILLED	2 mg	ORAL	unapproved drug other	7 sections
Concept DHA	HUMAN PRESCRIPTION DRUG LABEL	15	52747-621	CAPSULE, LIQUID FILLED	2 mg	ORAL	unapproved drug other	7 sections
Concept OB	HUMAN PRESCRIPTION DRUG LABEL	15	52747-620	CAPSULE	800 ug	ORAL	unapproved drug other	13 sections
Concept OB	HUMAN PRESCRIPTION DRUG LABEL	15	52747-620	CAPSULE	800 ug	ORAL	unapproved drug other	13 sections
Dexatran	HUMAN PRESCRIPTION DRUG LABEL	13	59088-643	CAPSULE	0.80 mg	ORAL	unapproved drug other	12 sections
Dynamiclear Rapid	HUMAN OTC DRUG LABEL	3	49836-033	LIQUID	40 mg	TOPICAL	EXPORT ONLY	15 sections
Dynamiclear Rapid	HUMAN OTC DRUG LABEL	3	49836-034	LIQUID	40 mg	TOPICAL	EXPORT ONLY	15 sections
Multitrace -4 Pediatric	HUMAN PRESCRIPTION DRUG LABEL	4	0517-9203	INJECTION, SOLUTION, CONCENTRATE	0.40 mg	INTRAVENOUS	UNAPPROVED DRUG OTHER	14 sections

Showing 1 to 10 of 30 entries

Previous1 2 3Next